🏛️ Verified NIH Record • Updated 2026-01-07
Abbott DBS Post-Market Study of Outcomes for Indications Over Time (NCT04071847)
🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Abbott Medical Devices
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this international study is to evaluate long-term safety and effectiveness of Abbott deep brain stimulation (DBS) systems for all indications, including Parkinson's disease, essential tremor or other disabling tremor and dystonia.
Who can join: Review the eligibility criteria below.
Location: University of Aizona Health Sciences — Tucson, Arizona
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (48 Sites)
Showing the first 25 of 48 sites.
- University of Aizona Health Sciences — Tucson, Arizona
- Cedars-Sinai Medical Center — Los Angeles, California
- University of California at Davis — Sacramento, California
- Colorado Neurodiagnostics — Littleton, Colorado
- Neurosurgery One — Littleton, Colorado
- University of Miami Hospital — Miami, Florida
- University of South Florida - Department of Neurology — Tampa, Florida
- Rush University Medical Center — Chicago, Illinois
- Indiana University — Indianapolis, Indiana
- Kansas University Medical Center — Kansas City, Kansas
- University of Louisville — Louisville, Kentucky
- Willis-Knighton Medical Center — Shreveport, Louisiana
- Beth Israe Deaconess Medical Center — Boston, Massachusetts
- Dartmouth Hitchcock Medical Center — Lebanon, New Hampshire
- Albany Medical Center — Albany, New York
- The Cleveland Clinic Foundation — Cleveland, Ohio
- Ohio State Medical — Columbus, Ohio
- Wright State University & Premier Health — Fairborn, Ohio
- Center for Interventional Pain & Spine — Exton, Pennsylvania
- Thomas Jefferson Department or Neurosurgery — Philadelphia, Pennsylvania
- Allegheny General Hospital Department of Neurosurgery — Pittsburgh, Pennsylvania
- Texas Movement Disorder Specialist — Georgetown, Texas
- University of Utah Hospital — Salt Lake City, Utah
- Princess Alexandra Hospital — Woolloongabba, Queensland
- Royal Melbourne Hospital - City Campus — Parkville, Victoria
📞 Contact the Study Coordinator
Phone: (650) 647-3396
Email: claudia.salazar4@abbott.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Movement Disorders
- ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders — Toronto, Ontario
- Handwriting Analysis in Movement Disorders. — London, Ontario
- Botulinum Toxin for the Treatment of Involuntary Movement Disorders — Bethesda, Maryland
- Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders — Birmingham, Alabama
- Neurophysiology of the Basal Ganglia, Thalamus, and Cerebellum in Patients With Movement Disorders — Philadelphia, Pennsylvania
- Towards Restoring Complex Movement After Paralysis: Algorithm Development With Healthy Participants — Los Angeles, California
Explore by condition: All Movement Disorders clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.